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Abstract
Decision support systems are used as a method of promoting consistent
guideline-based diagnosis supporting clinical reasoning at point of care. How-
ever, despite the availability of numerous commercial products, the wider ac-
ceptance of these systems has been hampered by concerns about diagnostic
performance and a perceived lack of transparency in the process of gener-
ating clinical recommendations. This resonates with the Learning Health
System paradigm that promotes data-driven medicine relying on routine
data capture and transformation, which also stresses the need for trust in
an evidence-based system. Data provenance is a way of automatically cap-
turing the trace of a research task and its resulting data, thereby facilitating
trust and the principles of reproducible research. While computational do-
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mains have started to embrace this technology through provenance-enabled
execution middlewares, traditionally non-computational disciplines, such as
medical research, that do not rely on a single software platform, are still
struggling with its adoption. In order to address these issues, we introduce
provenance templates – abstract provenance fragments representing mean-
ingful domain actions. Templates can be used to generate a model-driven
service interface for domain software tools to routinely capture the prove-
nance of their data and tasks. This paper specifies the requirements for a
Decision Support tool based on the Learning Health System, introduces the
theoretical model for provenance templates and demonstrates the resulting
architecture. Our methods were tested and validated on the provenance in-
frastructure for a Diagnostic Decision Support System that was developed
as part of the EU FP7 TRANSFoRm project.
Keywords: D2.1 (Software Engineering) Requirements/specification J.3
(Life and Medical Sciences): Health
data provenance, model-driven architectures, decision support systems
1. Introduction
The importance of data, its origins and quality, has long been recognised
in clinical research. In recent years, we have also witnessed increased re-
liance of clinical practice on data, through routine data capture in Electronic
Health Record systems, quality improvement initiatives at multiple levels,
and growing adoption of evidence-based medicine.
The patient safety implications of diagnostic error in family practice are
potentially severe for both patient and clinician [1]. The development of
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diagnostic clinical decision support systems (DSS) has long been advocated
to promote consistent guideline-based diagnosis supporting clinical reasoning
at point of care. However, the wider acceptance of these systems in clini-
cal practice has been much slower in happening despite the availability of
many commercial products. Concerns remain about diagnostic performance
and a perceived lack of transparency in first generation systems that deploy
an evidence knowledge base in the form of a black box that generates clin-
ical recommendations. These concerns about the quality of evidence and
the effort required in the longer term maintenance and sustainability of the
underlying evidence base supporting such systems has lead to research into
second generation tools supporting a more dynamic and iterative cycle of ev-
idence creation and update using a technical infrastructure developed under
the auspice of the Learning Health System (LHS) [2].
The Learning Health System community envisages every participant in
the health system (clinician, patient, researcher, insurer...) as both a pro-
ducer and consumer of data. Central to this vision is the notion of routine
capture, transformation and dissemination of both data and resulting knowl-
edge. Clinical studies, quality improvement initiatives, decision support, and
other scenarios can all then be associated with the routes that the data is tak-
ing through the LHS. The trust information associated with the data needs
to be made available at each step of these use cases, to support auditability
and transparency.
When applied to DSS-s, this trust requirement translates to the abil-
ity to readily demonstrate the clinical reasoning that was performed in a
clinical encounter, together with the recommendation received. In addition
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to supporting the auditability of the process, this capability also promotes
transparency and traceability from the recommendation back to the rules ap-
plied to produce the recommendation.The data provenance community has
been working on methods for ensuring reproducibility in scientific research,
through use of Semantic Web techniques and the W3C PROV standard [3],
that are highly relevant to the challenges of decision support in the LHS envi-
ronment. Computational provenance provides a uniform data-centered audit
trail of what actually happened during some task, and we shall describe how
these methods can be adapted to the needs of LHS.
There are two main techical challenges to be addressed in applying data
provenance to the Decision Support System scenario; firstly, how to have
heterogeneous, distributed software agents (security systems, rule engines...)
construct unified, verifiable provenance traces, and secondly, how to for-
mally guarantee that the resulting provenance traces will satisfy domain
constraints, often expressed in ontologies, and user data requirements.
In order to address these issues, we introduce provenance templates, ab-
stract provenance fragments representing meaningful domain actions that
can be used to generate a model-driven service interface for domain software
tools to routinely capture the provenance of their data and tasks. A template
defines a provenance graph in a generic manner by means of variables such
that it may be later instantiated and grafted onto pre-existing provenance
graphs. Importantly, this paper introduces the idea that templates may de-
scribe subgraphs subject to bounded iteration in both serial and parallel
manner.
The EU FP7 TRANSFoRm project [4] has developed a diagnostic deci-
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sion support tool that promotes numerous state-of-the-art practices of good
clinical decision support. These include precisely defined usability patterns,
integration with an electronic health record (EHR), allowing for recommen-
dations at the point of care as part of the clinician workflow, and a provenance
backend that captures provenance data about the computational aspects of
the diagnostic task.
The paper first introduces the concepts of the Learning Health System,
data provenance and decision support systems in section 2, before present-
ing the requirements of the LHS-enabled DSS, novel provenance templates
formalism and the associated provenance architecture in section 3. Section
4 demonstrates how the new model was used to construct DSS audit trails
in TRANSFoRm and in section 5 we consider how our approach addresses
the wider LHS requirements for trust in decision support systems, its impact
with respect to some recent developments, and list related work. Section 6
offers conclusions and presents pointers for future research.
2. Background
We shall now review the Learning Health System paradigm and the data
provenance technologies, and relate them to the challenges of clinical Decision
Support Systems, presenting as an example the DSS developed as part of the
TRANSFoRm project.
2.1. Learning Health System
The Learning Health System (LHS) movement aims to establish a next-
generation healthcare system, “... one in which progress in science, infor-
matics, and care culture align to generate new knowledge as an ongoing,
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natural by-product of the care experience, and seamlessly refine and deliver
best practices for continuous improvement in health and health care.” [5]
Each participant in the LHS, be they clinician, patient, or researcher, acts
as a consumer and a producer of knowledge, with the LHS providing: a)
routine and secure aggregation of data from multiple sources, b) conversion
of data to knowledge and c) dissemination of that knowledge, in actionable
form, to everyone who can benefit from it [2]. Thus, the LHS creates routes
for knowledge transfer between different parts of the health system, thereby
increasing its research and learning capacity.
Different data-driven scenarios, such as decision support systems, clini-
cal trial recruitment and management, epidemiological studies, all represent
applications within the LHS, each associated with the movements and pro-
cessing of data and knowledge. A number of LHS implementations have been
developed at varying scales [4, 6, 7, 8].
Attempts to define the core requirements of the Learning Health System
[5] have highlighted concerns about a perceived lack of transparency and
tracking in current systems demonstrating how clinical reasoning was actually
applied in any given clinical case. A fundamental feature of the LHS is the
generation and curation of clinical evidence using electronic data sources.
Such a process is critically dependent on a full transparency of how evidence
is produced, maintained and consumed as a means of generating trust in the
underlying system. Trust in the evidence base leads to the acceptance of
responsibility for the clinical recommendations made by it which is essential
if these tools are to gain widespread acceptance in the clinical community.
6
2.2. Data provenance
Put simply, data provenance describes what actually happened for some
data entity to achieve its current form. W3C standards body defines prove-
nance as a form of contextual resource metadata that describes entities and
processes involved in producing and delivering or otherwise influencing that
resource. Provenance provides a critical foundation for assessing authentic-
ity, enabling trust, and allowing reproducibility. The Office of the National
Coordinator (ONC) for Health IT describes it as attributes about the origin of
health information at the time it is first created and tracks the uses and per-
mutations of the health information over its lifecycle. Term data provenance
is used to establish the focus on data entities produced in the processes.
Data provenance provides traceability by automatically capturing the
trace of the research task and resulting data in a uniform and domain-
indepent way, thereby facilitating reproducible research. The original con-
cept comes from the eScience and cyber-infrastructure communities, where
it was used for capturing the exact parameterisations and configurations of
scientific workflows that produced a particular data set [9, 10]. Although
the original users of provenance data were the scientific programmers creat-
ing and maintaining research workflows, the increasing number of tools and
technologies available resulted in a wide array of stakeholders who can ben-
efit from provenance information using visual front-end tools and interactive
reports.
2.2.1. PROV model
The provenance technology, as defined in the W3C PROV standard[3],
provides a common platform for automated capture of metadata about the
7
data artifacts (e.g. databases, individual patient records, diagnostic recom-
mendations), all processes that use or create those artifacts, and all actors
that participate in those processes, such as clinicians, patients, researchers,
or computer software. The resulting provenance data stores are typically se-
mantically annotated databases, shared between all different software tools
in some software system that can be mined for generating new knowledge,
or investigated for audit purposes [11].
PROV is an interoperability standard, so there is no need for every system
to use it as its core data model, or even to use a graph data model, but
the W3C recommendation is for each provenance-enabled system to support
import and export in the PROV format.
Nodes in a provenance graph come in three flavours: entities, which
represent immutable states of a some data for which one wants to provide
a history, activities that produce and consume such entities and agents
associated in some capacity with either of the former. The edges of a graph
represent various inter-relations between the node types, such as usage, gen-
eration, and association [3]. Validity of graphs is defined using a number
of typing, ordering and impossibility constraints to be checked upon a nor-
malised form of a graph, if one exists [12]. All nodes have a mandatory
identifier given as a qualified name. A qualified name consists of an op-
tional namespace followed by a local name of form ns:name. Identifiers
belong to the prov namespace. Nodes and edges may be annotated with an
optional dictionary of attribute-value pairs, formed of a qualified name
and a data value, which can be used to attach ontological annotations onto
nodes, specifying their meaning in some domain. Fig. 1 demonstrates these
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entity
prov:id=ent1
activity
prov:id=act1
agent
prov:id=agt1
entity
prov:id=ent2
wasGeneratedBy
used wasAssociatedWith
ns:attribute=value
Figure 1: An example PROV graph using the standard representation of entities as yellow
ellipses, activities as blue rectangles and agents as orange pentagons. Node annotations
are shown as dashed grey boxes.
features in diagrammatic form using the standard PROV representation of
entities as yellow ellipses, activities as blue rectangles and agents as orange
pentagons. Node annotations are shown as dashed grey boxes.
2.3. Clinical Decision Support Systems
Decision support systems (DSS) have a long and sometimes controversial
research history [13, 14]. Clinical decision support system is defined as soft-
ware that is designed to be a direct aid to clinical decision-making, in which
the characteristics of an individual patient are matched to a computerized
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clinical knowledge base and patient-specific assessments or recommendations
are then presented to the clinician or the patient for a decision [15].
The exact nature of the patient-specific assessments or recommendations
and the delivery mechanism used to present that information to the patient
or clinician can vary greatly [16]. This has resulted in a number of different
types of clinical decision support system that address particular clinical areas,
ranging from computerised physician order entry and appropriate medicines
management, via risk calculators, diagnostic aids, and triggered alerts and
reminders to full electronic implementations of clinical guidelines.
The demonstrable efficacy of DSS in clinical practice however has been
limited. One reason is that research impacts of implementing such systems
have frequently been assessed as a technical driver of process change. Ide-
ally they should more usefully demonstrate a measurable positive impact on
practitioner performance that leads to directly attributable and measurable
improvement in patient outcomes [17]. But more promising results have been
demonstrated in research environments outside the clinical area of diagnos-
tics [18, 19, 20, 21].
Traditional approaches to diagnostic decision support have lacked broad
acceptance for a number of other well documented reasons: poor integra-
tion with EHRs and clinician workflow, static black-box rule based evidence
that lacks transparency and trust, usage of proprietary technical standards
hindering wider interoperability [22, 18, 23, 24, 25]. Despite these problems
there is an increasing recognition of the need to realise the potential value
of implementing decision support systems more generally. This is reflected
in their inclusion as important components of wider government ICT based
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health policy legislation in practice [26, 27].
The evolution of clinical decision support development reflects attempts
to address workflow and integration issues, interoperability standards and
also separation of the knowledgebase as a separate service distinct from the
tools themselves [28]. The focus has largely been on implementations of what
can be described as diagnostic symptom checkers, relying on a knowledge base
defined as a series of rules in the form of a database of knowledge facts. These
may be triggered or combined together in the form of guidelines based on
statements using a knowledge rule languages or rule engines such as Arden
Syntax [29], GLIF [30] and GELLO [31]. These approaches have led to a
recent shift towards model-based approaches to knowledge representation
for the purposes of clinical decision support[32].
2.4. TRANSFoRm Decision Support System
The EU FP7 TRANSFoRm project (2010-2015) [4], working with 20 part-
ners in 10 European countries, developed and evaluated a single unified in-
ternational platform to support main Learning Health System scenarios that
combine research and clinical practice, and reduce barriers to entry for us-
ing Electronic Health Record (EHR) systems and large medical data sources.
The project developed a next generation diagnostic decision support tool that
addresses many of the issues highlighted as being essential for good clinical
decision support [22]. These include integration with an electronic health
record (EHR) allowing for recommendations at the point of care as part of
the clinician workflow. An essential part that is the subject of this research
paper has been the support for the LHS concepts of transparent generation
and use of evidence in this system.
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Figure 2: TRANSFoRm Diagnostic decision support tool
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A prototype next generation diagnostic decision support system was de-
veloped in TRANSFoRm as part of a wider learning health system infrastruc-
ture. The tool, shown in Figure 2 is driven by clinical knowledge obtained
through a web service based clinical evidence repository providing model
driven prompting and recording of coded patient diagnostic cues supporting
diagnosis of 78 clinical conditions. The diagnostic decision support tool is
embedded and interoperable with the workflow of an EHR system in fam-
ily practice (Vision 3 EHR 1) as shown in Figure 2. The tool allows for
bottom-up input of observed patient cues (left-hand window) or top-down
drilling into and selection of evidence cues supporting a specific diagnosis
for investigation (right-hand window). A dynamically updated cue count is
maintained for each differential diagnosis indicating the number of evidence
cues observed as present for each diagnosis based on the patient cues recorded
during the consultation. This allows dynamic ranking of potential differential
diagnoses being considered (the most likely at the top) based on the patient
presenting reason for encounter, along with a record of the evidence sup-
porting each diagnosis under consideration. Upon exiting the tool a working
diagnosis can be confirmed and the coded evidence cues and current working
diagnosis can be saved back and recorded for future reference in the patient
EHR. A diagnostic evidence ontology [33] was created to serve as the cen-
tral information model for the DSS tasks, supporting provision of diagnostic
evidence for over 70 diagnostic conditions to decision support consumers us-
ing a web service interface. The evidence content can either be manually
1www.inps.co.uk/vision
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curated or populated using a separately developed data mining module [34].
The DSS system used the provenance infrastructure that forms a core part
of the TRANSFoRm middleware, together with the security framework and
semantic interoperability modules.
3. Material and methods
We shall now look into how TRANSFoRm implemented the provenance
infrastructure for its diagnostic decision support system. First, we shall
present the requirements stemming from the context of the Learning Health
System, and then present the theoretical framework for provenance template
architecture.
3.1. Reproducibility requirements of a provenance-enabled decision support
system
To inform our design for provenance templates as means of implementing
reproducibility in DSS, we now establish the reproducibility requirements
for a provenance-enabled DSS, by placing them in the context of the key
Learning Health System challenges [5]:
• An LHS that is trusted and valued by the public and all stakeholders.
Privacy, security, and transparency are key elements related to building
public trust and generating value. Trust and confidence at all stages
of the LHS operation are essential; from inputs to outputs (and out-
comes). This implies the need for traceability - a continuous trail
of data artifacts and operations on those artifacts, starting from the
data creation (e.g. routine data capture or import from a data source)
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through the transformations (knowledge base processing, rule applica-
tion) all the way to recommendations made by the DSS.
• An Adaptable, Self-improving, Stable, Certifiable, and Responsive LHS.
In the context of an adaptable system, how do we determine what
adapts? How can a system adaptably ingest, manage, refine, and emit
data from a rapidly growing source environment? What evidence must
be gathered about the development, design, and operation of the system
and about the environment in which it operates to enable certification?
The LHS software architectures need to provide a mechanism for such
evidence to be routinelly curated - gathered, organized, interpreted,
and maintained.
• An LHS Capable of Engendering a Virtuous Cycle of Health Improve-
ment. How do we develop ways to communicate the generated results,
information, or knowledge to others who may wish to replicate (or build
upon) the work done, as well as to the general public? How can the
computational procedures employed in the system be documented in
ways that are assuredly consistent, understandable, checkable, and re-
peatable, and how can the computational provenance of derived data
be tracked from its points of production through consumption and use?
These features rely on permanent auditability of the system, with all
neccessary audit data being automatically generated from the prove-
nance traces, and the models
Based on these, we define the key reproducibility requirements that apply
to decision support.
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1. System transparency. The black box approach and lack of trans-
parency results in the lack of trust and is cited as one of the main
reasons behind the poor take-up of clinical decision support systems
[35]. Therefore, in a provenance-enabled DSS, activities related to us-
age and generation of evidence need to be readily available for users to
review.
2. Auditability of recommendations. Medical/legal liability con-
cerns are considered a potential stumbling block for Decision Support
Systems [22], in that it is unclear who takes responsibility for various
elements in the DSS that could potentially go wrong. This relates to
the auditability of the system, which must enable the user to look
up a diagnostic recommendation and find all the relevant detail about
how it was made - evidence base used, patient cues entered, software
employed. The level of detail captured must be validated against the
required report granularity.
3. Understandability of data. The data that is captured about the
workings of the DSS needs to be not only accessible to the users (clini-
cians, auditors, researchers, patients) but it has to rely on standardized
concepts expressed in terminologies the users are familar with.
4. Validation readiness. In order to guarantee that the provenance
metadata being captured is at the right level of granularity and en-
compasses all the necessary features, the structure of the provenance
data needs to be modelled and verified separately from the software
implementation.
5. Traceability of evidence. The evidence repository will evolve
16
through the lifecycle of any recommendation software. It is impera-
tive that the content of the repository is subject to an orderly release
cycle and an associated quality assurance procedure, including an evi-
dence curation process. This is to ensure that the exact versions of the
knowledge bases used in each specific recommendation can be traced
back and analysed if needed.
6. Reproducibility of recommendations. An underlying feature for
a number of these characteristics is that the recommendations made
by the system are consistent and reproducible. An identical set of
patient cues presented to the same knowledge base and evidence service
software have to always yield the same result if there is to be trust in
the system. This is the core principle of reproducibility which needs to
be demonstrable and verifiable.
7. Responsibility. While the ultimate responsibility for a diagnosis
rests with the user who receives the recommendation and decides what
to do with it, in the LHS enabled DSS, the responsibility is shared with
the authors of the knowledge base, evidence curators, authors of the
reasoning algorithms used, and others. Thus, tracing both the actors
using the evidence and the ones generating the evidence is required in
order for full accountability to be achieved.
8. Privacy and security. Traditionally, security logs have been used
to keep track of what is going on in the system and investigate any
inappropriate actions. The provenance model needs to go beyond that
and be able to demonstrate that the patient data is never used contrary
to some set of rules. Furthermore, the transformations and anonymi-
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sations on patient data need to be captured in order for the trace to
be validated against privacy constraints.
9. Usability and scalability. An important feature of provenance
support in the DSS is not to do harm, and does not impede the nor-
mal running of the DSS. This requires seamless integration with no
noticeable degradation in performance that would adversely affect the
clinician in their daily routines. Furthermore, the system must be able
to scale up in line with the expected usage volume, so the provenance
store needs to be appropriately specified to cope with accumulation of
usage data over time.
These nine requirements were used to guide the design of our provenance
solution. We shall now introduce the theory behind provenance templates.
3.2. Provenance templates
Data provenance originated in research communities that rely on uniform
computational infrastructures, such as life and earth sciences. The result-
ing techniques [36] are not directly applicable to LHS scenarios and decision
support systems, due to heterogeneity of software systems involved and the
need to ensure consistency of provenance graphs produced by different sys-
tems. To that end, we introduce provenance templates as abstractions that
have domain meaning and can easily be mapped to the actions of the client
software tools. The formalism described here is based on W3C PROV [3]
as the current standard for representing provenance data as graph models.
However, the authors can see no barriers to generalising the approach to any
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graph-based provenance representation. 2
Informally, a provenance template is an abstract provenance graph which
may be instantiated to generate a concrete provenance graph, possibly con-
nected to some existing graph structure. We refer to that instantiation pro-
cess together with associated linkage and validation steps as graph generation.
The template may contain fragments which are to be repeated, for example, a
series of editing operations on some data, and it may specify the places where
the generated graph will be grafted (attached) onto some existing graph.
A template, T , is a provenance graph with some reserved annotations,
as described in 2.2.1, using a new provenance graph template namespace,
pgt. A variable is a placeholder for the node identifier to be provided
during generation process, that uses namespace var, e.g. var:x, var:y,
var:z etc. Nodes in templates may have variable identifiers or normal fixed
identifiers. The former are referred to as variable nodes and the latter
fixed nodes. Value variables are placeholders for values of attribute-
value annotation, rather than node identifiers and use the namespace vvar,
e.g.vvar:a, vvar:b, vvar:c. Variables are used to identify abstract nodes in
the template, and value variables to represent abstract properties associated
with either nodes or edges. The scope of variables and value variables is
the entire template and each distinct variable or value variable must occur
only once in a template. tvars(T ) denotes the set of all variables and value
variables occurring in a template T .
Fig. 3 shows a simple template T1, in diagrammatic form. There, ent1
2Indeed, the original TRANSFoRm implementation was based on Open Provenance
Model [37], a precursor to PROV.
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var:y
ent1
var:x
var:z
attr=vvar:a
act1
type=myOntology#Concept
Figure 3: Template T1
and act1 are fixed nodes representing respectively a concrete entity and
activity, whereas var:x, y and var:z are respectively an entity, an activity
and an agent whose identifiers have been replaced by variables. vvar:a is a
value variable taking the place of a value for the attr attribute annotated
upon the entity var:x.
The node act1 is annotated with the type value Concept taken from on-
tology myOntology. In this way the semantic type of the node is constrained,
allowing us to assign clear domain meaning to the concepts in the templates.
3.2.1. Series and parallel zones
An important requirement for our templates is to represent repetition in
provenance graphs, often used to describe similar segments that are created
by repeated instantiations of a template.
The concept of a repeated pattern in a template is represented using a
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zone Z, a connected subgraph that is to be iterated either in series or in
parallel upon generation of the graph. The attributes of zones belong to
the new zone namespace. Each zone has a unique identifier, zone:id and
may optionally be assigned minimum and maximum bounds zone:min and
zone:max, setting the minimum and maximum number of iterations allowed
for the zone. min(Z) and max(Z) respectively denote the minimum and
maximum bounds of the zone Z, if such values are defined.
A zone is defined by the set of template nodes which belong to it. A
node may only belong to one zone. A node that belongs to a zone is denoted
an internal node N ι, and its identifier must be a variable. Each internal
node of a zone is also annotated with the zone identifier using the pgt:zone
attribute, and inherits the zone’s type and bounds. In the figures below,
for readability purposes, zones are represented as frames around associated
internal nodes, in practice they are still PROV annotations, as described
in 2.2.1. A value variable is deemed to belong to a zone if it occurs in an
annotation of an internal node of that zone. Let zvars(Z) denote the set of
variables and value variables belonging to a given zone Z.
An external node, N , is any node of a template that does not belong
to a zone. A fixed external node represents a constant node with a fixed
value that is not instantiated further. Any external node of a template may
also act as a graft node, annotated with the pgt:graft flag, serving as the
point at which the template instance can be linked to another graph. A fixed
graft node may share the identifier of a node from a pre-existing graph and
similarly a variable graft node may be given an existing node identifier upon
substitution. We write tvars(T ) to represent the set of variables and value
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variables belonging to external nodes of a template T .
Every edge of a graph has a unique identifier. If the edge is between
two internal nodes, it is called an internal edge, while an edge between two
external nodes of a template T is called an external edge. Edges that enter
and exit the zone are called entry and exit edges, respectively. The entry
and exit edges of a zone define the manner in which the subgraphs generated
by zone iterations are connected to the instantiated external nodes of the
template.
A zone may be iterated in parallel or in series, specified by the zone:type
attribute that can take values of parallel or series respectively. Intu-
itively, a parallel iteration represents provenance derivations which may hap-
pen independently, where the entry and exit edges of the zone are duplicated
to create forking and synchronising points respectively in the final graph,
whereas a series type zone represents one which is repeated in sequential
fashion and the entry and exit edges define the connection to an initial and
terminal state.
A parallel zone must have at least one entry or exit edge in order to
ensure graph connectedness upon generation. Series type zones have some
additional notation and requirements. A recursive edge is a virtual edge of
a template by which generated serial iterations of a zone are to be joined.
Each such edge defines a connection to be generated from the instantiation
of an internal node in one iteration to the instantiation of an internal node
in the following iteration. Such an edge is declared by annotating the exit
node of the edge with the identifier of the entry node as the value of the
pgt:rec entry attribute. The entry node must be another internal node
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belonging to the same zone. Write rec(Z) for the set of recursive edges of a
zone Z. Each node given a value for the pgt:rec entry attribute must also
be given a value for the pgt:rec type specifying the PROV type of the edge
to be created. Each series type zone must have at least one recursive edge to
ensure a graph generated from the template is connected.
A template is valid if it is a valid provenance graph as defined by [12]
and also such that all recursive edges defined in the template also conform
to the typing and impossibility constraints applied to normal graph edges.
Fig. 4 shows a larger template T2, based upon T1 in which the previous
graph has now been identified as a parallel zone, zone1. The nodes ent1
and act1 are now identified by the variables var:u and var:t because all
internal nodes of a zone must have variables as identifiers. The graph has
been extended with new external nodes, some fixed, ent2, act2, ent3, and
some variable var:w and var:v, the last of which has been marked as a graft
node. This zone has been annotated with the zone:min attribute so as to
require a minimum of two iterations upon generation.
Fig. 5 shows another template T3 in which the original graph has again
been identified as a zone but this time of series type. The variable node var:u
has been annotated with the values for the pgt:rec entry and pgt:rec type
attributes, to specify the creation of used edges from each instance of var:u
to the instance of var:x in the following iteration of the zone. The number
of iterations of the zone has been limited to eight by use of the zone:max
attribute. The graph has been expanded with further external nodes in the
same way as for Fig. 4.
The resulting provenance graphs generated from these templates are shown
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var:y
var:t
var:x
var:z
attr=vvar:a
act2
ent2
var:w
var:v ent3pgt:graft
zone:id=zone1
zone.type=parallel
zone.min=2
var:u
Figure 4: Template T2 with a parallel zone
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zone:id=zone1
zone.type=serial
zone.max=8
pgt:recEntry=var:x
pgt:recType=used
var:y
var:t
var:x
var:z
attr=vvar:a
act2
ent2
var:w
var:v ent3pgt:graft
var:u
Figure 5: Template T3 with a series zone
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at the end of the next section.
3.3. Template generation
The generation of a particular instantiation of a provenance graph, G,
from a template is specified by a substitution. A substitution S is defined
as a mapping from a pair comprising a qualified name and a non-negative
integer representing the iteration number to a PROV value. Thus note
that no variables or value variables remain after a substitution has been
performed. The iteration number for the values substituted for external
variables and value variables of a template and for those occurring in the
first iteration of any zone is zero. Values substituted for variables or value
variables in any subsequent iterations of a zone are numbered sequentially in
the obvious manner.
To encode the templates in a standard way, we extend the notation of
PROV-N [38] by introducing a new predicate name sub and writing a sub-
stitution as a list of expressions of the form sub(qn, i, val) , where qn is the
qualified name of a variable or value variable, i is a non-negative integer and
val the value to be substituted for that name in that particular iteration.
In order for a substitution to be valid, every variable or value variable has
to have at least one value to be substituted and if multiple instantiations of a
zone are given, all variables and value variables belonging to that zone must
be given a value to be substituted in each iteration, and these iterations
must be numbered in increasing order. The total number of iterations to
be made for a zone Z specified in a substitution S is written bound(Z, S)
and must fall within any given minimum or maximum bound constraints
given for the zone, that is, min(Z) ≤ bound(Z, S) ≤ max(Z). Finally, for
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each variable, p ∈ tvars(T ), every value given for p in S must be a PROV
identifier, which must not occur in any pre-existing graph except if the node
to which v belongs has been labelled as a graft node. (Value variables may
be substituted for any PROV value.)
Template generation may proceed in two ways, either in a single-step
when given a complete substitution or step-wise using incremental substitu-
tions. Fig. 6 describes the generation of a graph G for a template T given a
complete valid substitution S. Graphs are represented as pairs comprising a
set of annotated vertices and a set of annotated edges. N ιi denotes the copy
of the internal node N ι in the ith iteration of a graph Gi and
+← represents
the addition of nodes or edges together with any associated annotations to
an existing graph as required. The functions copye and copyi generate a
copy of the external nodes, edges and annotations of a template and internal
nodes, edges and annotations of a zone respectively.
Generation may also occur in a step-wise fashion, e.g. when a larger
template is instantiated through several service calls by the client software.
The initial instantiation phase must be executed but then the state of the
generated graph may be saved. Instantiations of individual zones may then
be executed as needed and the graph state updated at each step. After all
zone iterations have been completed a final phase would be executed in which
the initial and terminal states of any series zone present are generated and
added to the graph. In this scenario, minimum and maximum bounds on
zone iterations must be checked after the final phase and the graph state
discarded if the conditions are not met. Further implementation details are
discussed in Section 4.3.
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Data: Template T and Substitution S
Result: Graph G
T0 ← copye(T)
foreach p ∈ tvars(T ) do p0 ← S(p, 0)
G
+← T0
foreach Z ∈ zones(T ) do
k ← bound(Z, S)− 1
for i← 0 to k do
Zi ← copyi(Z)
foreach p ∈ zvars(Z) do pi ← S(p, i)
G
+← Zi
if type(Z) = parallel then
foreach (M , N ι) ∈ entry(Z) do G +← (M, Ni)
foreach (M ι, N ) ∈ exit(Z) do G +← (Mi, N)
if type(Z) = series then
if not i = 0 then
foreach (M, N) ∈ rec(Z) do G +← (Mi−1, Ni)
if i = 0 then
foreach (M , N ι) ∈ entry(Z) do G +← (M0, N1)
if i = k then
foreach (M ι, N ) ∈ exit(Z) do G +← (Mk−1, Nk)
Figure 6: Generation algorithm
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act-y
ent1
ent-x
agt-z
attr=val-a
act1
Figure 7: Graph G1 generated from T1
3.4. Examples of Generated Graphs
To illustrate the generation process, consider the valid instantiation for
template T1 that is shown in Fig. 7 alongside the corresponding generated
graph G1. As previously noted, the template contains no zones and so all
that occurs is the substitution of the external variables and value variables
with those identifiers and values given by the instantiation.
Now consider the instantiation and provenance graph shown in Fig. 8
generated from the template T2 with a parallel type zone given in Fig. 4.
Generation of the zone results in the creation of forking nodes at act1 and
ent-w and synchronising nodes at ent-v and ent3. The internal node var:x
has been instantiated in the two iterations of the zone as ent-x1 and ent-x2
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act-y1
ent-t1
ent-x1
agt-z1
attr=val-a1
act2
ent2
ent-w
ent-v ent3
act-u1
act-y2
ent-t2
ent-x2
agt-z2
attr=val-a2
act-u2
Figure 8: Graph G2 generated from T2
and the other variables of the zone are processed similarly. Note that because
the node var:v was annotated as a graft node, the node ent-v may represent
a node from a pre-existing provenance graph.
Fig. 9 illustrates the provenance graph generated from the template T3
given in Fig. 5, using the same instantiation. The series type zone results
in the generation of two iterations joined by a recursive edge between the
nodes ent-u1 and ent-x2. The nodes act and ent-w are joined to the first
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act-y1
ent-t1
ent-x1
agt-z1
attr=val-a1
act2
ent2
ent-w
ent-v ent3
act-u1
act-y2
ent-t2
ent-x2
agt-z2
attr=val-a2
act-u2
Figure 9: Graph G3 generated from T3
iteration and ent-v and ent3 to the final iteration. Again ent-v may belong
to a pre-existing graph. Instantiation of variables proceeds as for G2 given
in Fig. 8.
4. Results
In order to demonstrate the applicability of the template-based data
provenance architecture to providing the relevant audit trail for decision sup-
port systems, we have impemented such an architecture within the context
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of the TRANSFoRm project. The starting point for defining the provenance
use cases was expressing their requirements as a set of basic provenance re-
lated questions, describing the provenance information that we require to be
automatically recorded and available through our decision support system:
1. Which decision support user was responsible for initiating a
decision support tool session that resulted in a specific di-
agnostic recommendation being generated on a certain date?
This is a typical audit-style question that assigns responsibility for the
diagnosis made.
2. What authentication was used for a user responsible for a
certain action? This type of question investigates the correctness of
the authentication for a particular action.
3. What clinical evidence cues (presenting symptoms) supported
the diagnosis of a particular diagnostic condition? The input
data provided to the diagnostic task needs to be persisted in order to
validate the recommendation made.
4. What clinical evidence data set(s) was a decision support rec-
ommendation based on? In addition to the presenting symptoms,
it is also important to understand what evidence base was used to
generate the recommendation.
5. What patients were diagnosed using a particular version of the
evidence base? An example of taint analysis, this type of question
allows us to find all instances where a potentially incorrect evidence
base was used and to trace the affected patients.
6. Which exact versions of the EHR system and the DSS were
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used in a particular diagnosis? Details about the software tools
present in a diagnosis, allowing the user to investigate if there are cor-
relations between certain diagnosis and the software used.
These questions could be asked by an internal or external auditor, either
directly, if the role is performed by a system administrator, or via a dedicated
user interface. In addition, questions 3. and 4. could be asked by a researcher
or clinician wanting to learn more about the guidelines currently in use,
via an appropriate user interface. Finally, the latter three questions are
highly relevant for investigating potential errors in the system and could be
performed by the DSS developer’s software team, most likely through a set
of direct queries.
One could think of further provenance questions that could be asked
about the operation of a decision support system, most notably around the
provenance of the evidence base itself and the creation and management of
rules therein, however in the TRANSFoRm project, the evidence base was
manually curated and thus not suitable for inclusion in our use cases.
4.1. Representing DSS concepts as PROV annotations
One strength of using PROV as the provenance representation language
is that it allows for provenance nodes and edges to be annotated with key-
value pairs. In order to precisely define the items that are being captured in
provenance traces, we have assigned each node an ontological concept and a
value, thus allowing provenance graphs to be queried using precise semantics.
The ontological concepts are drawn from three ontologies: TRANSFoRm
Software Profile ontology (TRANSFoRm SoftwareProfile) that comprises generic
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security and authentication terms, TRANSFoRm Clinical Informatics ontol-
ogy (TRANSFoRm rcto) that contains clinical research concepts including de-
cision support, and TRANSFoRm Clinical Informatics Provenance ontology
(TRANSFoRm rctpo) that maps TRANSFoRm rcto classes onto PROV terms
[39]. These ontologies are implemented in OWL and in addition to decision
support, cover the full range of Learning Health System concepts in obser-
vational studies and clinical trials that were required by TRANSFoRm.
TRANSFoRm SoftwareProfile’s design ensures that each user action in
the system can be traced back to the login session during which it hap-
pened. This is done using OpenSession and CloseSession classes and the
SAMLAssertion, Session and UserName data entity classes, reflecting the
fact that TRANSFoRm used Security Assertion Markup Language (SAML)
to implement its security framework. The OpenSession and CloseSession
describe the activities related when a user opens or closes an application. The
former activity uses the data provided by authentication services in form of
SAML entities, identifying the person accessing the application. This activ-
ity generates a Session object, which is linked with the following activities
during the system execution, including the CloseSession.
TRANSFoRm rcto contains classes and relationships relevant to decision
support systems, covering clinical evidence and its use in the diagnostic pro-
cess. These include activities associated with updating and utilization of
the clinical evidence repository (CE Repository), and its use by the deci-
sion support system (DSS system). While collecting clinical evidence rules,
CollectDiagnosticCues activities update the CE Repository. During the
diagnostic task, a set of diagnostic cues, CE PatientDiagnosisCueSet, are
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compiled and used to perform EvidenceComparison resulting in a set of
matching rules, CE MatchingRulesSet and the final diagnosis recommenda-
tion DSSRecommendation. TRANSFoRm rctpo creates subclasses of relevant
TRANSFoRm rcto classes that are also subclasses of PROV-O ontology [40]
concepts, creating identifiers and text labels which are then used as PROV
annotations onto provenance template nodes, as shown in Table 1.
4.2. Clinical Decision Support Templates
Two use cases for the TRANSFoRm decision support system were de-
fined and expressed in the form of provenance templates. The first describes
the user logging into the system and getting authenticated by the security
framework, while the second supports provenance collection during evidence
consumption and subsequent clinical recommendation provided by the de-
ployed evidence repository accessed by the decision support tool itself. Note
that the two template instantiations are invoked by two different pieces of
software in the TRANSFoRm system, the former by the security subsystem
and the latter by the decision support tool itself.
In order to represent the semantic categories, each node in the template
is further constrained by the ontological annotations described in section 4.1
and shown as PROV key-value attribute pairs in the grey boxes.
The template in Fig. 10 shows the task of a user logging into the de-
cision support system via TRANSFoRm secure middleware, using Security
Assertion Markup Language (SAML) authentication and obtaining a session
object which is later used to authorise the user to perform actions on the
system.
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TRANSFoRm concept Provenance concept
TRANSFoRm SoftwareProfile#SAMLAssertion Entity
TRANSFoRm SoftwareProfile#Session Entity
TRANSFoRm SoftwareProfile#User Agent
TRANSFoRm SoftwareProfile#UserName Entity
TRANSFoRm SoftwareProfile#OpenSession Activity
TRANSFoRm SoftwareProfile#CloseSession Activity
rctpo#CE Repository Agent
rctpo#Patient Agent
rctpo#DSS system Agent
rctpo#EHR system Agent
rctpo#CollectDiagnosticCues Activity
rctpo#PatientDiagnosisCueSet Entity
rctpo#EvidenceComparison Activity
rctpo#CE MatchingRulesSet Entity
rctpo#DSS Recommendation Entity
Table 1: TRANSFoRm ontological terms mapped onto provenance concepts in PROV-O
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var:open
var:session
var:user
var:securityCertificate
var:ehrSystem
pgt:graft
type:rctpo#EHR_system
type:PROV_SoftwareProfile#User
type:PROV_SoftwareProfile#open
SoftwareSession
type:PROV_SoftwareProfile#SAML
Assertion
type:PROV_SoftwareProfile#Session
Figure 10: Session template showing the login activity producing a session entity and a
security certificate entity
The template in Fig. 11 depicts the operation of the diagnostic deci-
sion support system. External nodes var:ehr and var:patient denote
the Electronic Health Record system used and the patient presenting for
diagnosis, respectively, while var:ceRepo and var:dss represent the clin-
ical evidence repository used and the decision support system. The zone
represents a single diagnosis task for the patient, of which it is assumed
there will be several, with different sets of cues (var:cueSet) producing
different diagnostic recommendations (var:diagRec). Patient symptoms
are noted (var:collectCues) and used to generate a record of the pa-
tient visit var:patientVisit, which is used by the decision support system
var:dssSys to make a comparison (var:evidenceComp) against the available
clinical evidence in its knowledge base var:ceRepo to generate a matching
set of rules var:matchSet and a diagnostic recommendation var:diagRec.
Note that the two templates overlap on the session entity, which is a
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var:collectCues
var:cueSet
var:dss
var:evidenceComp
var:diagRecvar:matchSet
zone:id=diagnosis
zone.type=parallel
var:patient ehr
pgt:graft
type:rctpo#EHR_system
pgt:graft
type:rctpo#Patient
var:ceRepo
pgt:graft
type:rctpo#CE_Repository
pgt:graft
type:rctpo#DSS_system
var:session
pgt:graft
type:PROV_SoftwareProfile#Session
type:rctpo#EvidenceComparison
type:rctpo#PatientDiagnosis
CueSet
type:rctpo#CE_Matching
RulesSet
type:rctpo#DSS_Recommendation
type:rctpo#CollectDiagnosticCues
Figure 11: Diagnosis template where a set of diagnosis is made for a patient, each produc-
ing diagnostic recommendations
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Figure 12: Instantiated template in Neo4J database
graft node in the second template, so there needs to be one login provenance
fragment for each diagnosis fragment. One example of the provenance data
collected in the TRANSFoRm DSS system is shown in Figure 12, visualised
in the Neo4J database.
4.3. Provenance template server architecture
The architecture of the system is illustrated in Figure 13. The overall
structure is simple. The provenance server itself is accessible as a web service
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Template Engine
Instantiation
Validator
Graph
Synthesis
Neo4j
Graph 
database
Web Service 
REST
Endpoint
Provenance
Validator
Provenance
database
provenance
template
provenance
substitution
instantiated
template
provenance
graph
ETL
SPARQL 
query 
endpoint
Cypher 
query 
endpoint
Figure 13: Server Architecture. Graphs stored in the main database are transferred to
Neo4J graph database via Extract-Transform-Load (ETL) to facilitate interactive query-
ing.
via an endpoint offering a RESTful API with the data stored using a MySQL
relational database with a D2RQ relational-to-RDF adapter [41] allowing
querying via SPARQL language that is targetted at semantically annotated
data. The data is also transferred into a Neo4j graph database using Extract-
Transform-Load (ETL), with an instance of the Neo4j web server allowing
captured data to be queried and visualised by users via a browser-based
interface using the Cypher query language [42].
The main subcomponent of the server is the template engine, which is
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responsible for validating substitutions for a given template and generating
the subsequent graph. Provenance graphs are converted to and from the
database format by a translator component. Since Neo4j employs a higher-
level, graph-theoretic model by a translator component, the ETL represents
PROV node types as Neo4j node labels and PROV annotations as Neo4j
properties.
As described in section 3.2, the current prototype implementation em-
ploys a graph model similar to that of Neo4j. Graphs are described in terms
of vertices and edges which may be annotated by dictionaries of named data
values. Templating, provenance and user-defined data are kept in separate
namespaces. This design allows the engine to be agnostic as regards the
provenance standard used by the server, whether that be PROV, the Open
Provenance Model (OPM) or any other. However, the remaining compo-
nents, the REST endpoint, provenance validator and graph translator are
specific to a particular standard and must be implemented on a case-by-case
basis along with adapters for the template engine.
The main use case is that for storing a graph generated from a template
and accompanying instantiation and proceeds as follows. Given a description
of the provenance template and instantiation for that template, both are
serialised in JSON format and sent to the REST endpoint in a single API
call to generate and store the data. After being received by the server, this
description is deserialised and then passed to the template engine where it is
first validated in order to ensure that the substitution is valid for the template
provided. If this succeeds then the graph synthesis component proceeds to
generate the expanded graph following the algorithm described in Fig. 6.
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This graph is then run through the provenance validator component which
checks the validity of the generated graph. If the graph is valid then it is
passed to the translator which commits this to the database. Note that if
a template includes graft nodes then the provenance validator may need to
query the database about existing graphs in order to assess the validity of
the generated graph. The second use case, the storage of a complete graph
is a subcase of the first. A description of the graph is presented to the server
directly via the endpoint at which point it is immediately handed to the
provenance validator component rather than to the template engine, and
then stored if deemed valid.
As discussed in Section 3.3, it may be also be desirable to generate graphs
from a template in a step-wise rather than single-step fashion. In this sit-
uation, three API methods would be published. An initialisation method
would first provide a template and a substitution for external variables and
value variables of the template. Following this, one or more calls to a zone
iteration method would then be made for each zone within the template pro-
viding substitution data for the instantiation of a new iteration of the zone.
A finalization method would then signal that a template was considered
complete which would trigger the completion of series type zones, validation
of the instantiation and of the generated graph. Intermediate graph states
would be commited as temporary graph fragments in the database and either
commited fully or rolled back following final validation.
4.4. Provenance data collected
The TRANSFoRm diagnostic decision support system was evaluated us-
ing a high-fidelity simulation of the clinical consultation using real EHR
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system in a simulated clinic environment. The evaluation employed 34 real
physicians and a series of actors reenacting real patient scenarios, around
three presenting problems (chest pain, shortness of breath and dyspnea) re-
sulting in a total of 408 patient encounters. Each clinician would be logging
into a system once per day, and producing one diagnostic template instan-
tiation with 3-4 zone repetitions per encounter. In a real-world clinic with
8 general practitioners, seeing 40 patients per day, which is standard for an
inner London practice, this would translate into around 1000 zone instanti-
ations per day, giving us a scale of the data size and velocity involved in a
real life environment.
4.5. Queries developed
The traditional way of querying provenance data uses SPARQL as a se-
mantically enabled query language. In our architecture, the provenance data
store accepts SPARQL queries and returns answers. However, we are also
interested in the interactive query capabilities, for which the Neo4J database
front-end has suitable tooling via its Cypher query language [42] and brows-
ing features. In this type of queries, the reply serves as a starting point for
interactive graph exploration, which is not feasible in SPARQL. Thus, in or-
der to demonstrate the viability of using provenance graphs as the audit trail
of the decision support tools, we have mapped our initial set of questions onto
queries in both SPARQL and the Cypher graph query language, making use
of the ontologies we developed. Note that for readability in Cypher queries
we are using human readable labels derived from ontological categories.
Query 1: Which decision support user was responsible for initiating a deci-
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sion support tool session that resulted in a specific diagnostic recommenda-
tion being generated on a certain date?
SPARQL:
select ?userName
?oss provo:wasControlledBy ?userName
?oss rdf:type TRANSFoRm_SoftwareProfile:OpenSession
?s provo:wasGeneratedBy ?oss
?s rdf:type TRANSFoRm_SoftwareProfile:Session
?cdc provo:used ?s
?cdc rdf:type rctpo:collectDiagnosticCues
?dcs rdf:type rctpo:diagnosticCueSet
?dcs provo:wasGeneratedBy ?cdc
?ec rdf:type rctpo:EvidenceComparison
?ec provo:used ?dcs
dssRecommendation.getProvURI() provo:wasGeneratedBy ?ec
Cypher:
MATCH (n:ENTITY {Concept:"DSS Recommendation",
Value:"Appendicitis, unqualified",
Timestamp:"2015-02-24T00:00:00"})-[*]->(m:ENTITY {Concept:"UserNameAgent"})
RETURN m.Value;
Query 2: What authentication was used for a user responsible for a certain
action?
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SPARQL:
select ?saml
?oss provo:used ?saml
?oss rdf:type TRANSFoRm_SoftwareProfile:OpenSession
?s provo:wasGeneratedBy ?oss
?s rdf:type TRANSFoRm_SoftwareProfile:Session
action.getProvURI() provo:Used ?s
Cypher:
MATCH (m:ACTIVITY {Concept:"Collect Diagnostic Cues")-->
(n:ENTITY {Concept:"Session"}) --()->(o:ENTITY {Concept:"SAMLAssertion"})
WHERE ID(m)=346204
RETURN o.Value;
Query 3: What clinical evidence cues supported the diagnosis of a particu-
lar diagnostic condition?
SPARQL:
select ?clEvidenceRepository
datasetRecommendation.getProvURI() provo:wasDerivedFrom ?p
?p rdf:type provo:Activity
?p used ? clEvidenceRepository
?clEvidenceRepository rdf:type rctpo:CE_Repository
Cypher:
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MATCH (n:ENTITY {Concept:"DSS Recommendation",
Value:"Acute pyelonephritis"})-->()-->
(m:ENTITY {Concept:"Diagnostic Cue Set"})
RETURN distinct m.Value;
Query 4: What clinical evidence data set(s) was a decision support recom-
mendation based on?
SPARQL:
select ?clEvidenceRepository
datasetRecommendation.getProvURI() provo:WasGeneratedFrom ?p
?p rdf:type provo:Activity
?p provo:wasControlledBy ?clEvidenceRepository
?clEvidenceRepository rdf:type rctpo:CE_Repository
Cypher:
MATCH (n:ENTITY {Concept:"DSS Recommendation"})
-[:WAS_CONTROLLED_BY]->
(m:ENTITY {Concept:"Clinical Evidence Repository"})
WHERE ID(n)=346530
RETURN m.Value;
Query 5: What patients were diagnosed using a particular version of the
evidence base?
SPARQL:
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select ?p
?p rdf:type rctpo:Patient
?cdc rdf:type rctpo:collectDiagnosticCues
?cdc provo:wasControlledBy ?p
?dcs rdf:type rctpo:diagnosticCueSet
?dcs provo:wasGeneratedBy ?cdc
?ec rdf:type rctpo:EvidenceComparison
?ec provo:used ?dcs
?ec provo:wasControlledBy ?cer
?cer rdf:type rctpo:clinicalEvidenceRepository
?cer rctpo:hasVersion "2.3"
Cypher:
MATCH (p:AGENT {Concept:"Patient"}) <-[*]-
(n:ENTITY {Concept:"Evidence Comparison"})-[:WAS_CONTROLLED_BY]-->
(m:AGENT {Concept:"Clinical Evidence Repository"})
WHERE m.Version=2.3
RETURN distinct p.Value;
Query 6: Which exact versions of the EHR system and the DSS were used
in a particular diagnosis?
SPARQL:
select ?ehr_version, ?dss_version
?ehr rctpo:hasVersion ?ehr_version
?dss rctpo:hasVersion ?dss_version
?ehr rdf:type rctpo:EHR_system
47
?dss rdf:type rctpo:DSS_system
?cdc rdf:type rctpo:collectDiagnosticCues
?cdc provo:wasControlledBy ?ehr
?cdc provo:wasControlledBy ?dss
?dcs rdf:type rctpo:diagnosticCueSet
?dcs provo:wasGeneratedBy ?cdc
?ec rdf:type rctpo:EvidenceComparison
?ec provo:used ?dcs
dssRecommendation.getProvURI() provo:wasGeneratedBy ?ec
Cypher:
MATCH (n:ENTITY {Concept:"DSS Recommendation"})-[*]->
(m:AGENT {Concept:"DSS system"}),
n-[*]->(o:AGENT {Concept:"EHR system"})
WHERE ID(n)=346530
RETURN m.Value, o.Value;
As can be seen from the structure of implemented queries, the SPARQL
queries operating on the RDF representation are, in effect, recreating the
structure of the instantiated template to ask questions. Cypher queries
meanwhile can make use of generic graph connectivity queries through the
-[*]-> construct, which, while computationally expensive, provides for a
more expressive query construction. Furthermore, further navigation and
querying from the original result is simpler and faster in Neo4J, which sup-
ports the exploratory investigation of provenance traces. Broadly speaking,
the strength of Cypher is in processing queries once the entry point has been
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found [43], while SPARQL running on RDF representations is better at ag-
gregated queries that need to traverse the entirety of the database. However,
with improved indexing capabilities in Neo4J v3, this may be subject to
change and we are planning to do the full comparison on a larger, simulated,
data set as part of future work.
5. Discussion
In section 3, nine requirements were defined for achieving reproducibility
in decision support systems, which we now revisit to demonstrate how our
solution addresses them:
1. System transparency. The provenance trace in any of its forms
provides the insight into the workings of the decision support system,
with the granularity defined by the ontologies used, allowing varying
levels of detail.
2. Auditability of recommendations. To ensure recommendations
made are auditable, the system must guarantee that the required subset
of information is present in the provenance traces. Templates provide
exactly this functionality, by specifying the metadata that will be cap-
tured and supporting queries such as Query 3 and Query 5 in section
4.5.
3. Understandability of data. Use of domain ontologies (e.g. TRANS-
FoRm’s Clinical evidence ontology) in the provenance node annotations
allows queries to be posed in terms of standardised terminologies.
4. Validation readiness. Provenance templates are independent of
any concrete implementation and the architecture presented is model-
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driven. Thus, the model can be validated separately from the software
tool.
5. Traceability of evidence. In the provenance model we have devel-
oped, each version of an evidence base is considered a separate state,
and thus is modelled as a separate entity, with each recommendation
connected to a single evidence base version. This enables answering
questions such as the one posed in Query 4 and Query 6 in section 4.5.
6. Reproducibility of recommendations. Rule engines used in de-
cision support systems have to be deterministic if they are to pass
validation. Provenance data provides the historical data to conduct
that validation and search for the presence of instances where the same
input may have resulted in different outputs.
7. Responsibility. By storing provenance traces in connected graphs
containing the details of the security and authentication mechanisms
used, the use of authentication templates guarantees that each action
can be traced back to the user or software responsible, as shown in
Query 1, Query 2, and Query 6 in section 4.5.
8. Privacy and security. The provenance data stored contains the
unbroken chain of actions that transformed various pieces of data in
the system. If this includes confidential information that should not be
presented to the system users, there are several techniques for abstract-
ing parts of provenance data according to predefined security policies
[44, 45, 46].
9. Usability and scalability. The provenance system is hidden away
from the decision support system users, so by implementing light-
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weight components and asynchronous REST calls, we ensure that its
presence does not impede the clinical consultation process by introduc-
ing delays. With regards to the scalability, the use of templates allows
us to precisely determine what will be the volume of the provenance
data collected and the velocity at which it accumulates, allowing the
system administrators to implement appropriate storage policies.
By addressing these, we believe that our approach can be used as a ba-
sis for a wide variety of decision support applications. It should be noted
that the template design process should always be done in collaboration with
the domain experts to ensure correctness and applicability, and that we do
not expect the two TRANSFoRm templates to be necessarily sufficient for
each possible use case, merely to serve as starting points, together with the
ontologies developed. Given that the surrounding architecture is domain-
agnostic, we can reasonably expect that it can support use cases at varying
levels of complexity, e.g. a production quality implementation would require
a conformance testing suite and independent validation of templates devel-
oped, ensuring, among other things, that domain ontology constraints are
not violated.
The SPARQL and Cypher interfaces allow system developers to quickly
query the accrued provenance data, but in order to expose this information
to a broader range of end-users, such as institutional and external auditors,
commissioning groups, and even clinicians, more visual tooling is necessary.
TRANSFoRm implemented two prototype front-end tools: a web interface
containing several representative queries such as the ones above, hiding away
the complexity and allowing the user to enter only the relevant parameters
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and obtain back the results in graph form; and a set of interactive reports
containing tabular and chart information, implemented in Eclipse Business
Intelligence Reporting Toolkit (BIRT). This approach is currently being ex-
plored further by the authors in a follow-up industrial collaboration that shall
develop end-user query tools.
Historically, a major challenge for adoption of decision support systems
has been the lack of transparency in the recommendations and rules that
those recommendations have been based on. In order to evaluate whether
provenance technologies can make a tangible difference in clinical practice,
and determine whether this information can benefit clinicians directly, prove-
nance elements need to be embedded into a DSS user interface and a full
usability study, e.g. using Technical Acceptance Model, shall be necessary.
Thus, evaluation of provenance technologies should encompass both the com-
putational and other operational cost involved in running the tools, and the
effort needed to design the necessary models and queries should also be mea-
sured. Another issue of note is the quality of collected provenance data, its
completeness and accuracy, which should be improved by the use of prove-
nance templates. In order to evaluate this, a separate method of data collec-
tion should be specified for each provenance question, and the two compared
against each other. These and other software engineering challenges related
to provenance are being addressed through the work on PRIME method-
ology [47]. The authors are applying and extending this work within the
LHS-Stroke secondary stroke prevention project that is part of the CLAHRC
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South London programme3.
While this paper focused on diagnostic decision support systems, because
this was the DSS use case in the TRANSFoRm project, identical issues arise
in other types of DSS such as patient management tools and higher level
reporting tools such as management portals used by comissioners, insurers,
and health administrators. Indeed some of these have been found to have
more impact on patient care than diagnostic systems [21].
5.1. Recent developments
The practical need for research into the area of computable provenance
for diagnostic decision support has been starkly highlighted by recently re-
ported events in UK general practice surrounding incorrect recommendations
being made by a decision support system [48]. The QRISK 2 score is a val-
idated, accepted and widely used decision support aid for predicting the
cardiovascular risk in patients in the UK, that is integrated with EHR sys-
tems via a parameterised programmatic interface allowing triggering of rules
from within the EHR. One particular implementation of the QRISK2 score
with a widely used general practice EHR system, was found to be overstat-
ing the reported cardiovascular risk in some patients resulting in the wrong
guidance to the physician to advise patients to take statin medication to
lower that risk. This has resulted in a full investigation by the Medical and
Health Products Regulatory Agency (MHRA) in the UK. The initial suspi-
cion has focussed on the communication of patient data between the EHR
and the QRISK2 calculator, rather than the implementation of the QRISK2
3http://www.clahrc-southlondon.nihr.ac.uk/stroke
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tool itself. This has resulted in the need for the EHR vendor in question
to identify GP practices to notify potentially impacted patients and to re-
examine their cardiovascular risk. The provenance work as described in this
research can be seen to be highly applicable in such a logistically difficult
scenario. This damage limitation is a classic example of provenance taint
analysis as described in section 4, and in such scenario our system could be
used to identify:
• Potential GP practices where the QRISK2 score has been used to give
diagnostic recommendations. (similar to Query 1, looking into practice
instead of a user)
• Diagnostic recommendations actually made for identifiable patients
from identifiable EHR systems that actually used the QRISK2 tool.
(similar to Query 5)
• The actual patient cue sets that were submitted to the QRISK 2 tool
interface to make the diagnostic recommendations (Query 3)
• The returned diagnostic recommendation risk score result for each in-
dividual patient involved. (similar to Query 5, including risk score in
the template model)
Due to this unfortunate incident, we expect the topics of trust and au-
ditability of decision support systems to come even more to the forefront.
5.2. Tracing evidence evolution
In more generic decision support systems that rely on a collection of rules
that are combined to produce recommendations, the questions on the lineage
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of rules used to produce a recommendation become important: What data
sets and algorithms were used in rule production? How was the rule vali-
dation performed? We considered these questions during the TRANSFoRm
project, and produced example templates that would satisfy these questions,
but they were not implemented at this stage due to the data mining frame-
work remaining separate from the rest of the system. In this extension to
the model, each addition, change, or deletion of a rule in the evidence base
is tracked, whether the rule has been manually modified or a result of an
automated data mining algorithm.
5.3. Related work
The prototype of template-based provenance was introduced in its early
form in [49, 50] and successfully demonstrated the feasibility of using prove-
nance templates to support a large, heterogeneous software infrastructure,
albeit missing the theoretical foundation and full architecture presented here.
A separate effort at Southampton [51] is currently looking into lower-level
provenance templates that abstract individual PROV variables, rather than
larger graph fragments. The instantiation then proceeds by performing cross-
products of all variable value spaces, as restricted by constraints. The concept
of substructures in provenance graphs has also been researched in the context
of SPARQL queries for RDF provenance repositories and generic graph frag-
ment queries that use a graph motif with a set of constraints on that motif
[52]. Related efforts have also been made in the area of graph summarisation
[53] which use the graph structure as a basis for summarising and compress-
ing relational knowledge by detecting patterns and compressing structural
knowledge encoded within relational graphs, including repetitive or sequen-
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tial structures. Finally, a body of work exists in abstracting provenance
graphs for security purposes. ZOOM system uses the concept of user views
to abstract nodes that are not of interest to the consumer [54]. The TACLP
[44], ProvAbs [45], and ProPub [46] approaches use security policy defini-
tions to determine which components of the provenance graph to include
and which to abstract.
6. Conclusions and future work
A defining characteristic of the Learning Health System is the trust that
must be placed in every aspect of the system [5]. The participants in the LHS
must be able to gain insight into its workings if they are to put faith in its
actions and entrust it with their data. Furthermore, the system must possess
introspective qualities in order to be able to learn about itself and continously
improve, engendering a Virtuous Cycle of Health Improvement. This implies
capabilities for data and knowledge sharing between the research and clinical
actors, under clear and automatically enforced privacy and security rules. A
semantically clear and unambiguous provenance trace provides a mechanism
for such sharing.
This paper has looked into the reproducibility challenges facing decision
support systems, guided by the LHS paradigm, and proposed a solution
based on data provenance technologies and abstract provenance template
constructs. The semantic complexity of the medical domain modelled was
modeled using ontologies annotated onto provenance graphs, and the software
architecture used the templates to facilitate provenance capture from the
decision support tool. The work was originally prototyped in the diagnostic
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decision support system developed within the TRANSFoRm project where
it was used to capture data from over four hundred simulated diagnostic
patient encounters and key analytical queries on that data were shown.
Ultimately, this work contributes to the efforts in integrating trust into
computerised decision support systems, enabling transparency and auditabil-
ity by creating a basis for implementing validation mechanisms. The com-
plexity of decision support systems offers numerous opportunities for prob-
lems to arise, from quality of data capture and accuracy of EHR interactions
via usability issues to algorithmic errors in rule design. Thus, their increased
use puts more and more focus on the techniques for ensuring correctness of
the tasks involved. Data provenance offers the mechanism to achieve this,
and through use of provenance templates, we have shown how such infras-
tructure can be implemented in the context of decision support systems.
In the era of Big Data, deep learning systems such as IBM Watson, and
other technologies that often rely on black-box analytical environments, it is
of paramount importance to support transparency in computerised systems
which actions may have direct consequences on human lives. A particularly
dangerous assumption of some Big Data evangelists is that with a sufficiently
large data, correlation can replace causality in our analytical models. While
this may be perfectly fine for market analysis questions such as investigating
customer churn or supermarket shopping baskets, medical research in par-
ticular depends on full understanding of finer points such as bias, data qual-
ity, and statistical significance to derive its conclusions. Thankfully, there
is an increasing understanding of the fact that we require not just intelli-
gent machines but intelligible machines [55]. Rather than avoiding Big Data
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technologies, we need to understand which aspects of it are well-suited to
medical research, and then build research software frameworks that support
transparency, auditability, replicability and reproducibility [56].
The version of the DSS provenance infrastructure employed in TRANS-
FoRm is currently being updated for use by further projects, such as the
DSS for prevention of secondary stroke in patients in South London. The
tool, developed as part of the CLAHRC South London programme 4, has
been designed by the team at King’s College London with key stakeholders
including clinicians, patients, and commissioners, and the provenance mod-
ule will provide audibility and traceability of decisions made with the tool.
With the recent changes in scalability support in Neo4J, we intend to do
away with the relational/RDF store and use Neo4J as our main database
storage, providing a SPARQL query front end for backwards compatibility.
Furthermore, we plan to add more templates that cover non-diagnostic deci-
sion support scenarios and implement some more advanced PROV concepts
such as hyperedges representing relations between more than two nodes.
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Appendix A. Full PROV-N specification of graphs shown in Fig-
ures
Appendix A.1. Figure 3
entity(var:x, [attr=vvar:a])
activity(var:y)
entity(ent1)
agent(var:z)
activity(act1)
wasGeneratedBy(var:x, var:y)
used(var:y, ent1)
wasAssociatedWith(var:y, var:z)
wasGeneratedBy(ent1, act1)
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Appendix A.2. Figure 4
entity(var:x, [attr=vvar:a, zone:id=zone1, zone:type=parallel,
zone:min=2])
activity(var:y, [zone:id=zone1, zone:type=parallel, zone:min=2])
entity(var:t, [zone:id=zone1, zone:type=parallel, zone:min=2])
agent(var:z, [zone:id=zone1, zone:type=parallel, zone:min=2])
activity(var:u, [zone:id=zone1, zone:type=parallel, zone:min=2])
wasGeneratedBy(var:x, var:y)
used(var:y, ent1)
wasAssociatedWith(var:y, var:z)
wasGeneratedBy(ent1, act1)
entity(ent2)
activity(act2)
entity(var:w)
entity(var:v)
entity(ent3)
entity(var:v, [pgt:graft])
wasGeneratedBy(ent2, act2)
used(act2, var:x)
wasDerivedFrom(var:w, var:x)
used(var:u, var:v)
used(var:u, ent3)
Appendix A.3. Figure 5
entity(var:x, [attr=vvar:a, zone:id=zone1, zone:type=serial,
zone:max=8])
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activity(var:y, [zone:id=zone1, zone:type=serial, zone:max=8])
entity(var:t, [zone:id=zone1, zone:type=serial, zone:max=8])
agent(var:z, [zone:id=zone1, zone:type=serial, zone:max=8])
activity(var:u, [zone:id=zone1, zone:type=serial, zone:max=8,
pgt:recEntry=var:x, pgt:recType:used])
wasGeneratedBy(var:x, var:y)
used(var:y, ent1)
wasAssociatedWith(var:y, var:z)
wasGeneratedBy(ent1, act1)
entity(ent2)
activity(act2)
entity(var:w)
entity(var:v)
entity(ent3)
entity(var:v, [pgt:graft])
wasGeneratedBy(ent2, act2)
used(act2, var:x)
wasDerivedFrom(var:w, var:x)
used(var:u, var:v)
used(var:u, ent3)
Appendix A.4. Figure 7
entity(ent-x, [attr=val-a])
activity(act-y)
entity(ent1)
agent(agt-z)
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activity(act1)
wasGeneratedBy(ent-x, act-y)
used(act-y, ent1)
wasAssociatedWith(act-y, agt-z)
wasGeneratedBy(ent1, act1)
Appendix A.5. Figure 8
entity(ent-x1, [attr=val-a1])
activity(act-y1)
entity(ent-t1)
agent(agt-z1)
activity(act-u1)
wasGeneratedBy(ent-x1, act-y1)
used(act-y1, ent-t1)
wasAssociatedWith(act-y1, agt-z1)
wasGeneratedBy(ent-t1, act-u1)
entity(ent-x2, [attr=val-a2])
activity(act-y2)
entity(ent-t2)
agent(agt-z2)
activity(act-u2)
wasGeneratedBy(ent-x2, act-y2)
used(act-y2, ent-t2)
wasAssociatedWith(act-y2, agt-z2)
wasGeneratedBy(ent-t2, act-u2)
entity(ent2)
73
activity(act2)
entity(ent-w)
entity(ent-v)
entity(ent3)
wasGeneratedBy(ent2, act2)
used(act2, ent-x1)
used(act2, ent-x2)
wasDerivedFrom(ent-w, ent-x1)
wasDerivedFrom(ent-w, ent-x2)
used(act-u1, ent-v)
used(act-u2, ent-v)
used(act-u1, ent3)
used(act-u2, ent3)
Appendix A.6. Figure 9
entity(ent-x1, [attr=val-a1])
activity(act-y1)
entity(ent-t1)
agent(agt-z1)
activity(act-u1)
wasGeneratedBy(ent-x1, act-y1)
used(act-y1, ent-t1)
wasAssociatedWith(act-y1, agt-z1)
wasGeneratedBy(ent-t1, act-u1)
entity(ent-x2, [attr=val-a2])
activity(act-y2)
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entity(ent-t2)
agent(agt-z2)
activity(act-u2)
wasGeneratedBy(ent-x2, act-y2)
used(act-y2, ent-t2)
wasAssociatedWith(act-y2, agt-z2)
wasGeneratedBy(ent-t2, act-u2)
entity(ent2)
activity(act2)
entity(ent-w)
entity(ent-v)
entity(ent3)
wasGeneratedBy(ent2, act2)
used(act2, ent-x1)
wasDerivedFrom(ent-w, ent-x1)
used(act-u2, ent-v)
used(act-u2, ent3)
used(act-u1, ent-x2)
Appendix A.7. Figure 10
entity(var:session, [type:PROV_SoftwareProfile#Session])
entity(var:securityCertificate, [type:PROV_SoftwareProfile#SAMLAssertion])
activity(var:open, [type:PROV_SoftwareProfile#Session])
agent(var:ehrSystem, [pgt:graft, type:rctpo#EHR_system])
agent(var:user, [type:PROV_SoftwareProfile#User])
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Appendix A.8. Figure 10
entity(var:matchSet, [zone:id=diagnosis, zone:type=parallel, type:rctpo#CE_MatchingRulesSet])
entity(var:diagRec, [zone:id=diagnosis, zone:type=parallel, type:rctpo#DSS_Recommendation])
activity(var:evidenceComp, [zone:id=diagnosis, zone:type=parallel, type:rctpo#EvidenceComparison])
entity(var:cueSet, [zone:id=diagnosis, zone:type=parallel, type:rctpo#PatientDiagnosisCueSet])
agent(var:ceRepo, [pgt:graft, type:rctpo#CE_Repository])
activity(var:collectCues, [zone:id=diagnosis, zone:type=parallel, type:rctpo#CollectDiagnosticCues])
entity(var:session, [pgt:graft, type:PROV_SoftwareProfile#Session])
agent(var:patient, [pgt:graft, type:rctpo#Patient])
agent(ehr, [pgt:graft, type:rctpo#EHR_system])
agent(var:dss, [pgt:graft, type:rctpo#DSS_system])
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